The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Use of bone modifying agents for metastatic castrate-resistant prostate cancer.
 
Aaron Philip Mitchell
No Relationships to Disclose
 
Akriti Mishra Meza
Stock and Other Ownership Interests - Johnson & Johnson/Janssen; Teladoc
 
Azeez Farooki
Consulting or Advisory Role - Amgen
 
Katherine Panageas
Stock and Other Ownership Interests - Adicet Bio; AzurRx BioPharma; catalyst biotech; Chinook Therapeutics; Codexis; Curis; Dynavax Technologies; Fluidigm; T2 Biosystems; Viking Therapeutics; Vincera Pharma/Vincerx Pharma
 
Peter B. Bach
Leadership - Delfi Diagnostics; Oncology Analytics
Stock and Other Ownership Interests - Delfi Diagnostics; EQRx; Oncology Analytics
Consulting or Advisory Role - EQRx
Research Funding - Kaiser Permanente; Laura and John Arnold Foundation; NIH
Travel, Accommodations, Expenses - Oncology Analytics
 
Allison Lipitz-Snyderman
No Relationships to Disclose
 
Michael J. Morris
Stock and Other Ownership Interests - Doximity
Consulting or Advisory Role - Advanced Accelerator Applications; Athenex; Bayer; Curium Pharma; Endocyte; Exelixis; Johnson & Johnson; Lantheus Medical Imaging; NCCN; Novartis; ORIC Pharmaceuticals; Progenics
Research Funding - Bayer (Inst); Corcept Therapeutics (Inst); Endocyte (Inst); Janssen (Inst); Progenics (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Endocyte; Fujifilm